Efficacy and safety of ticagrelor monotherapy following a brief DAPT vs. prolonged 12-month DAPT in ACS patients post-PCI: a meta-analysis of RCTs-Reference-Cited by-同舟云学术

Efficacy and safety of ticagrelor monotherapy following a brief DAPT vs. prolonged 12-month DAPT in ACS patients post-PCI: a meta-analysis of RCTs

Published:2024-09-12 Issue: Volume: Page:
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Qamar Usama,Naeem Farhan,Maqsood Muhammad Talha,Khan Maleeka Zamurad,Imtiaz Zeeshan,Saeed Fatima,Gupta Neelesh,Brohi Fnu Zafarullah,Mkpozi Celestine,Sattar Yasar^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00228-024-03747-w.pdf

Reference52 articles.

1. Ibáñez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio AL, Crea F, Goudevenos J, Halvorsen S, Hindricks G, Kastrati A, Lenzen M, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P, Gale CP (2017) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 39(2):119–177. https://doi.org/10.1093/eurheartj/ehx393

2. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O’Gara PT, Sabatine MS, Smith PK, Smith SC (2016) 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention, 2011 ACCF/AHA guideline for coronary artery bypass graft surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable. Circulation. https://doi.org/10.1161/cir.0000000000000404

3. Valgimigli M, Bueno H, Byrne RA, Collet J, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann F, Petričević M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN, Badimon L, Kinnaird T (2017) 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur Heart J 39(3):213–260. https://doi.org/10.1093/eurheartj/ehx419

4. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Rużyłło W, Gottlieb S, Neumann F, Ardissino D, De Servi S, Murphy SA, Riesmeyer JS, Weerakkody GJ, Gibson CM, Antman EM (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357(20):2001–2015. https://doi.org/10.1056/nejmoa0706482

5. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus HA, Mahaffey KW, Scirica BM, Skene AM, Steg PG, Storey RF, Harrington RA (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045–1057. https://doi.org/10.1056/nejmoa0904327